title: Rotavirus vaccination in central Europe.
abstract: Each year, rotavirus (RV) infection is the leading cause of acute gastroenteritis requiring hospitalisation and of nosocomially transmitted diseases in children younger than 5 years across Central European Vaccination Awareness Group (CEVAG) countries; however, inadequate surveillance systems and lack of routine RV testing still exist in most CEVAG countries, making it difficult to accurately assess the present burden of acute RV gastroenteritis in the younger population. Furthermore, routine immunisation of infants with RV vaccines has not been implemented, and no official and uniform recommendations exist in most of the countries in these territories. The present study provides CEVAG country-specific estimates of the disease burden of RV gastroenteritis among the youngest population and presents evidence-based advice on the use of RV vaccines in the region, while providing a framework for vaccination at the national level.
authors.affiliation: National Institute of Child Health, Budapest, Hungary. zsmeszner@ogyei.hu
authors.forename: Zsófia
authors.initials: Z
authors.lastname: Mészner
authors.forename: Ioana
authors.initials: I
authors.lastname: Anca
authors.forename: Francis
authors.initials: F
authors.lastname: André
authors.forename: Roman
authors.initials: R
authors.lastname: Chlibek
authors.forename: Milan
authors.initials: M
authors.lastname: Čižman
authors.forename: Paweł
authors.initials: P
authors.lastname: Grzesiowski
authors.forename: Atanas
authors.initials: A
authors.lastname: Mangarov
authors.forename: Marko
authors.initials: M
authors.lastname: Pokorn
authors.forename: Roman
authors.initials: R
authors.lastname: Prymula
authors.forename: Darko
authors.initials: D
authors.lastname: Richter
authors.forename: Nuran
authors.initials: N
authors.lastname: Salman
authors.forename: Pavol
authors.initials: P
authors.lastname: Šimurka
authors.forename: Eda
authors.initials: E
authors.lastname: Tamm
authors.forename: Goran
authors.initials: G
authors.lastname: Tešović
authors.forename: Ingrid
authors.initials: I
authors.lastname: Urbancikova
authors.forename: Vytautas
authors.initials: V
authors.lastname: Usonis
authors.forename: Dace
authors.initials: D
authors.lastname: Zavadska
mesh_terms: D002675:Child, Preschool; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D005061:Europe, Eastern / Q000453:epidemiology; D019317:Evidence-Based Medicine; D005759:Gastroenteritis / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy; D017048:Health Care Costs; D006291:Health Policy; D006801:Humans; D015994:Incidence; D007223:Infant; D032541:Mass Vaccination / Q000009:adverse effects / Q000191:economics; D015995:Prevalence; D012401:Rotavirus / Q000276:immunology; D012400:Rotavirus Infections / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control* / Q000628:therapy; D022243:Rotavirus Vaccines / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D014421:Turkey / Q000453:epidemiology; D014837:Voluntary Health Agencies; D014944:World Health Organization
chemical_list: D022243:Rotavirus Vaccines